{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:06:58Z","timestamp":1792642018833,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To compare the efficacy and safety of remimazolam besylate and propofol for deep sedation in critically ill patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this single-center, prospective, randomized, controlled pilot study, patients in the intensive care unit (ICU) requiring deep sedation were randomized to receive remimazolam besylate or propofol intravenously. Deep sedation was defined as a Richmond Agitation and Sedation Scale (RASS) score of \u2212\u00a04 or \u2212\u00a05. Sedation depth was monitored using RASS and Narcotrend Index (NI). The primary outcome was the percentage of time within the target sedation range without rescue sedation. The secondary outcomes included ventilator-free hours within 7\u00a0days, successful extubation, length of ICU stay, and 28-day mortality. Adverse events during the interventional period were also recorded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty patients were assigned to each group. The median (IQR) RASS score was \u2212\u00a05.0 (\u2212\u00a05.0, \u2212\u00a04.0), and the median (IQR) NI value was 29.0 (21.0, 37.0) during the intervention period. Target RASS was reached a median of 100% of the sedation time in the two groups. No significant differences were observed in ventilator-free hours within 7\u00a0days, successful extubation, length of ICU stay, or 28-day mortality among groups. Hypotension occurred in 16 (53.3%) patients of remimazolam group and 18 (60.0%) patients of propofol group (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). No patient experienced bradycardia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Remimazolam besylate appears to be an effective and safe agent for short-term deep sedation in\u00a0critically ill patients. Our findings warrant large sample-sized randomized clinical trials.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13054-023-04760-8","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T08:02:37Z","timestamp":1701676957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study"],"prefix":"10.1186","volume":"27","author":[{"given":"Yun","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqing","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,4]]},"reference":[{"key":"4760_CR1","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1164\/rccm.201102-0273CI","volume":"185","author":"SB Patel","year":"2012","unstructured":"Patel SB, Kress JP. Sedation and analgesia in the mechanically ventilated patient. Am J Respir Crit Care Med. 2012;185:486\u201397.","journal-title":"Am J Respir Crit Care Med"},{"key":"4760_CR2","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW, Skrobik Y, Gelinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46:e825\u201373.","journal-title":"Crit Care Med"},{"key":"4760_CR3","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1007\/s00134-020-06307-9","volume":"46","author":"G Chanques","year":"2020","unstructured":"Chanques G, Constantin JM, Devlin JW, Ely EW, Fraser GL, Gelinas C, et al. Analgesia and sedation in patients with ARDS. Intensive Care Med. 2020;46:2342\u201356.","journal-title":"Intensive Care Med"},{"key":"4760_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00134-022-06901-z","volume":"49","author":"EB Kassis","year":"2023","unstructured":"Kassis EB, Beitler JR, Talmor D. Lung-protective sedation: moving toward a new paradigm of precision sedation. Intensive Care Med. 2023;49:91\u20134.","journal-title":"Intensive Care Med"},{"key":"4760_CR5","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","volume":"115","author":"LJ Antonik","year":"2012","unstructured":"Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics. Anesthesia Analgesia. 2012;115:274\u201383.","journal-title":"Anesthesia Analgesia"},{"key":"4760_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/01.anes.0000267503.85085.c0","volume":"107","author":"GJ Kilpatrick","year":"2007","unstructured":"Kilpatrick GJ, McIntyre MS, Cox RF, Stafford JA, Pacofsky GJ, Lovell GG, et al. CNS 7056: a novel ultra-short-acting Benzodiazepine. Anesthesiology. 2007;107:60\u20136.","journal-title":"Anesthesiology"},{"key":"4760_CR7","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1097\/CM9.0000000000002243","volume":"135","author":"Y Tang","year":"2022","unstructured":"Tang Y, Yang X, Shu H, Yu Y, Xu J, Pan S, et al. Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study. Chin Med J. 2022;135:2134\u20136.","journal-title":"Chin Med J"},{"key":"4760_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13054-022-04168-w","volume":"26","author":"Y Tang","year":"2022","unstructured":"Tang Y, Yang X, Yu Y, Shu H, Yuan Y, Liu H, et al. Remimazolam besylate versus propofol for long-term sedation during invasive mechanical ventilation: a pilot study. Crit Care. 2022;26:279.","journal-title":"Crit Care"},{"key":"4760_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jointm.2021.01.003","volume":"1","author":"D Battaglini","year":"2021","unstructured":"Battaglini D, Sottano M, Ball L, Robba C, Rocco PRM, Pelosi P. Ten golden rules for individualized mechanical ventilation in acute respiratory distress syndrome. J Intensive Med. 2021;1:42\u201351.","journal-title":"J Intensive Med"},{"key":"4760_CR10","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1007\/s00134-020-06288-9","volume":"46","author":"EC Goligher","year":"2020","unstructured":"Goligher EC, Jonkman AH, Dianti J, Vaporidi K, Beitler JR, Patel BK, et al. Clinical strategies for implementing lung and diaphragm-protective ventilation: avoiding insufficient and excessive effort. Intensive Care Med. 2020;46:2314\u201326.","journal-title":"Intensive Care Med"},{"key":"4760_CR11","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1056\/NEJMoa1005372","volume":"363","author":"L Papazian","year":"2010","unstructured":"Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363:1107\u201316.","journal-title":"N Engl J Med"},{"key":"4760_CR12","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1056\/NEJMoa1904710","volume":"380","author":"Y Shehabi","year":"2019","unstructured":"Shehabi Y, Howe BD, Bellomo R, Arabi YM, Bailey M, Bass FE, et al. Early sedation with dexmedetomidine in critically Ill patients. N Engl J Med. 2019;380:2506\u201317.","journal-title":"N Engl J Med"},{"key":"4760_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/CCM.0b013e3182783b72","volume":"41","author":"J Barr","year":"2013","unstructured":"Barr J, Fraser GL, Puntillo K, Ely EW, Gelinas C, Dasta JF, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41:263\u2013306.","journal-title":"Crit Care Med"},{"key":"4760_CR14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s00134-012-2762-2","volume":"39","author":"M Le Guen","year":"2013","unstructured":"Le Guen M, Liu N, Bourgeois E, Chazot T, Sessler DI, Rouby JJ, et al. Automated sedation outperforms manual administration of propofol and remifentanil in critically ill patients with deep sedation: a randomized phase II trial. Intensive Care Med. 2013;39:454\u201362.","journal-title":"Intensive Care Med"},{"key":"4760_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bpa.2005.08.010","volume":"20","author":"S Kreuer","year":"2006","unstructured":"Kreuer S, Wilhelm W. The narcotrend monitor. Best Pract Res Clin Anaesthesiol. 2006;20:111\u20139.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"4760_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.938940","volume":"9","author":"Y Qiu","year":"2022","unstructured":"Qiu Y, Gu W, Zhao M, Zhang Y, Wu J. The hemodynamic stability of remimazolam compared with propofol in patients undergoing endoscopic submucosal dissection: a randomized trial. Front Med (Lausanne). 2022;9: 938940.","journal-title":"Front Med (Lausanne)"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04760-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04760-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04760-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T20:06:07Z","timestamp":1701720367000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04760-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,4]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4760"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04760-8","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,4]]},"assertion":[{"value":"17 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and national and institutional standards. The study was approved by the Ethics Committee of Wuhan Union Hospital (2022-0539-01). Written informed consent was obtained from legally authorized representatives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"474"}}